Buy Sophiris Bio Stock | SPHS Stock Price & Latest News | Public
SPHS

Sophiris Bio

$0.00 (0.00%)Today
    Small Market Cap

    About SPHS

    Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enl...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.11
    -0.17
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.17

    Actual EPS
    Q3 2020

    Stats

    Market Cap$344,7k
    Volume
    Price-to-Earnings Ratio2.78
    Dividend Rate
    Dividend Yield
    1 Year High$0.36
    1 Year Low$0.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app